Human-induced pluripotent stem cell (iPSC)-derived kidney organoids have the potential to advance studies to kidney development and disease. However, reproducible generation of kidney organoids is a challenge. A large variability in the percentage of nephron structures and the expression of kidney-specific genes was observed among organoids, showing no association with iPSC lines. To associate the quality of kidney organoid differentiation with predictive markers, a ranking system was developed based on the ratio of nephron structure determined by histological examination. Well-differentiated organoids were defined as organoids with >30% nephron structure and vice versa. Subsequently, correlations were made with expression profiles of iPSC markers, early kidney development markers, and fibrosis markers. Higher expression of sex-determining region Y-box 2 (SOX2) during differentiation was associated with poorly differentiated kidney organoid. Furthermore, early secretion of basic fibroblast growth factor (FGF2) predicted poorly differentiated kidney organoid. Of interest, whereas cadherin-1 (CDH1) expression in kidney organoids indicates distal tubules formation, onefold higher CDH1 expression in iPSC predicted poor differentiation. High expression of the stromal progenitor marker Forkhead Box D1 (FOXD1) and significantly increased TGFβ levels were found in well-differentiated kidney organoids. These early expression profiles could predict the outcome of kidney organoid formation. This study helps to improve the robustness of kidney organoid protocols.
Get full access to this article
View all access options for this article.
References
1.
TakasatoM, ErPX, ChiuHS, MaierB, BaillieGJ, FergusonC, PartonRG, WolvetangEJ, RoostMS, Chuva de Sousa LopesSM and LittleMH. (2015). Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature, 526:564–568.
2.
WuH and HumphreysBD. (2020). Single cell sequencing and kidney organoids generated from pluripotent stem cells. Clin J Am Soc Nephrol, 15:550–556.
3.
ShankarAS, HoornEJ, GribnauJ, BaanCC and HoogduijnMJ. (2019). Current state of renal regenerative therapies. Transplantation, 103:250–261.
4.
TaguchiA and NishinakamuraR. (2017). Higher-order kidney organogenesis from pluripotent stem cells. Cell Stem Cell, 21:730–746.e736.
5.
TakasatoM and LittleMH. (2016). A strategy for generating kidney organoids: recapitulating the development in human pluripotent stem cells. Dev Biol, 420:210–220.
6.
TakasatoM, ErPX, ChiuHS and LittleMH. (2016). Generation of kidney organoids from human pluripotent stem cells. Nat Protoc, 11:1681–1692.
7.
MorizaneR and BonventreJV. (2017). Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells. Nat Protoc, 12:195–207.
8.
GlassNR, TakasakoM, ErPX, TitmarshDM, HidalgoA, WolvetangEJ, LittleMH and Cooper-WhiteJJ. (2020). Multivariate patterning of human pluripotent cells under perfusion reveals critical roles of induced paracrine factors in kidney organoid development. Sci Adv, 6:eaaw2746.
9.
WellerA, SorokinL, IllgenEM and EkblomP. (1991). Development and growth of mouse embryonic kidney in organ culture and modulation of development by soluble growth factor. Dev Biol, 144:248–261.
10.
LittleMH and CombesAN. (2019). Kidney organoids: accurate models or fortunate accidents. Genes Dev, 33:1319–1345.
11.
PhipsonB, ErPX, CombesAN, ForbesTA, HowdenSE, ZappiaL, YenHJ, LawlorKT, HaleLJ, et al. (2019). Evaluation of variability in human kidney organoids. Nat Methods, 16:79–87.
12.
WuH, UchimuraK, DonnellyEL, KiritaY, MorrisSA and HumphreysBD. (2018). Comparative analysis and refinement of human PSC-derived kidney organoid differentiation with single-cell transcriptomics. Cell Stem Cell, 23:869–881.e868.
13.
SubramanianA and SidhomEH. (2019). Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation. Nat Commun, 10:5462.
14.
CombesAN, ZappiaL, ErPX, OshlackA and LittleMH. (2019). Single-cell analysis reveals congruence between kidney organoids and human fetal kidney. Genome Med, 11:3.
15.
NamSA, SeoE, KimJW, KimHW, KimHL, KimK, KimTM, JuJH, GomezIG, et al. (2019). Graft immaturity and safety concerns in transplanted human kidney organoids. Exp Mol Med, 51:1–13.
16.
BantounasI, RanjzadP, TengkuF, SilajdžićE, ForsterD, AsselinMC, LewisP, LennonR, PlaggeA, et al. (2018). Generation of functioning nephrons by implanting human pluripotent stem cell-derived kidney progenitors. Stem Cell Rep, 10:766–779.
17.
de EschCE, GhazviniM, LoosF, Schelling-KazaryanN, WidagdoW, MunshiST, van der WalE, DoubenH, GunhanlarN, et al. (2014). Epigenetic characterization of the FMR1 promoter in induced pluripotent stem cells from human fibroblasts carrying an unmethylated full mutation. Stem Cell Rep, 3:548–555.
18.
WarlichE, KuehleJ, CantzT, BrugmanMH, MaetzigT, GallaM, FilipczykAA, HalleS, KlumpH, et al. (2011). Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol Ther, 19:782–789.
19.
StefanskaA, KenyonC, ChristianHC, BuckleyC, ShawI, MullinsJJ and PéaultB. (2016). Human kidney pericytes produce renin. Kidney Int, 90:1251–1261.
20.
ShankarAS, DuZ, MoraHT, van den BoschTPP, KorevaarSS, Van den Berg-GarreldsIM, BindelsE, Lopez-IglesiasC, Clahsen-van GroningenMC, et al. (2021). Human kidney organoids produce functional renin. Kidney Int, 99:134–147.
21.
MengXM, Nikolic-PatersonDJ and LanHY. (2016). TGF-β: the master regulator of fibrosis. Nat Rev Nephrol, 12:325–338.
22.
SubramanianA, SidhomEH, EmaniM, VernonK, SahakianN, ZhouY, Kost-AlimovaM, SlyperM, WaldmanJ, et al. (2019). Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation. Nat Commun, 10:5462.
23.
ZhangS, BellE, ZhiH, BrownS, ImranSAM, AzuaraV and CuiW. (2019). OCT4 and PAX6 determine the dual function of SOX2 in human ESCs as a key pluripotent or neural factor. Stem Cell Res Ther, 10:122.
24.
WangZ, OronE, NelsonB, RazisS and IvanovaN. (2012). Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell, 10:440–454.
25.
ChouYF, ChenHH, EijpeM, YabuuchiA, ChenowethJG, TesarP, LuJ, McKayRD and GeijsenN. (2008). The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells. Cell, 135:449–461.
26.
LiL, BennettSA and WangL. (2012). Role of E-cadherin and other cell adhesion molecules in survival and differentiation of human pluripotent stem cells. Cell Adh Migr, 6:59–70.
27.
XuJ, LiuH, ParkJS, LanY and JiangR. (2014). Osr1 acts downstream of and interacts synergistically with Six2 to maintain nephron progenitor cells during kidney organogenesis. Development, 141:1442–1452.
28.
HumphreysBD, ValeriusMT, KobayashiA, MugfordJW, SoeungS, DuffieldJS, McMahonAP and BonventreJV. (2008). Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell, 2:284–291.
KobayashiA, ValeriusMT, MugfordJW, CarrollTJ, SelfM, OliverG and McMahonAP. (2008). Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell, 3:169–181.
31.
RanghiniEJ and DresslerGR. (2015). Evidence for intermediate mesoderm and kidney progenitor cell specification by Pax2 and PTIP dependent mechanisms. Dev Biol, 399:296–305.
32.
FettingJL, GuayJA, KarolakMJ, IozzoRV, AdamsDC, MaridasDE, BrownAC and OxburghL. (2014). FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney. Development, 141:17–27.
33.
HumphreysBD, LinSL, KobayashiA, HudsonTE, NowlinBT, BonventreJV, ValeriusMT, McMahonAP and DuffieldJS. (2010). Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol, 176:85–97.
ZhaoW, WangX, SunKH and ZhouL. (2018). α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis. PLoS One, 13:e0191031.
36.
KwongG, MarquezHA, YangC, WongJY and KottonDN. (2019). Generation of a purified iPSC-derived smooth muscle-like population for cell sheet engineering. Stem Cell Rep, 13:499–514.
37.
von HolstA, EgbersU, ProchiantzA and FaissnerA. (2007). Neural stem/progenitor cells express 20 tenascin C isoforms that are differentially regulated by Pax6. J Biol Chem, 282:9172–9181.
38.
PollenAA, NowakowskiTJ, ChenJ, RetallackH, Sandoval-EspinosaC, NicholasCR, ShugaJ, LiuSJ, OldhamMC, et al. (2015). Molecular identity of human outer radial glia during cortical development. Cell, 163:55–67.
39.
GewinL, BulusN, MernaughG, MoeckelG, HarrisRC, MosesHL, PozziA and ZentR. (2010). TGF-beta receptor deletion in the renal collecting system exacerbates fibrosis. J Am Soc Nephrol, 21:1334–1343.
40.
ZohnIE, LiY, SkolnikEY, AndersonKV, HanJ and NiswanderL. (2006). p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell, 125:957–969.
41.
KahataK, DadrasMS and MoustakasA. (2018). TGF-β family signaling in epithelial differentiation and epithelial-mesenchymal transition. Cold Spring Harb Perspect Biol, 10:a022194.
42.
PlisovSY, YoshinoK, DoveLF, HiginbothamKG, RubinJS and PerantoniAO. (2001). TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis. Development, 128:1045–1057.
43.
YangYL, LiuYS, ChuangLY, GuhJY, LeeTC, LiaoTN, HungMY and ChiangTA. (2009). Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors. Endocrinology, 150:727–740.
44.
MorrisseyJ, HruskaK, GuoG, WangS, ChenQ and KlahrS. (2002). Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13 Suppl, 1:S14–21.
45.
ZeisbergM, ShahAA and KalluriR. (2005). Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem, 280:8094–8100.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
